Bibliography

Found 74 results

Filters: Author is Gelman, Benjamin [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Gelman B, Schuenke KW, Soukup VM. Abnormal white matter genes drive an acquired channelopathy in subcortical dementia associated with HIV infection. In: Journal of Neuropathology and Experimental Neurology. Vol. 63. Journal of Neuropathology and Experimental Neurology. ; 2004. p. 553.

Clifford DB, Vaida F, Kao Y-ting, Franklin D, Letendre S, Collier AC, Marra CM, Gelman B, McArthur JC, Morgello S, et al. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 ;84(3):241-50.

Levine AJ, Quach A, Moore D, Achim C, Soontornniyomkij V, Masliah E, Singer EJ, Gelman B, Nemanim N, Horvath S. Accelerated epigenetic aging in brain is associated with pre-mortem HAND. Journal of Neurovirology. 2015 .

Levine AJ, Quach A, Moore DJ, Achim CL, Soontornniyomkij V, Masliah E, Singer EJ, Gelman B, Nemanim N, Horvath S. Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders. J Neurovirol. 2016 ;22(3):366-75.

Gelman B, Soukup VM, Schuenke KW, Keherly MJ, Holzer CE, Richey FJ, Lahart CJ. Acquired neuronal channelopathies in HIV-associated dementia. Journal of Neuroimmunology [Internet]. 2004 ;157(1-2):111-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15579287

Gelman B. Age-associated neuromorphology in the acquired immunodeficiency syndrome. In: Journal of Neuropathology and Experimental Neurology. Vol. 58. Journal of Neuropathology and Experimental Neurology. ; 1999. p. 517.

Jensen BK, Monnerie H, Mannell MV, Gannon PJ, Espinoza CAkay, Erickson MA, Bruce-Keller AJ, Gelman B, Briand LA, R. Pierce C, et al. Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders. [Internet]. 2015 ;74(11):1093 - 1118. Available from: http://dx.doi.org/10.1097/NEN.0000000000000255

Morgan EE, Woods SPaul, Letendre S, Franklin D, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman B, et al. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.

Panos SE, Hinkin CH, Singer EJ, Thames AD, Patel SM, Sinsheimer JS, Del Re AC, Gelman B, Morgello S, Moore D, et al. Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehavioral HIV Medicine [Internet]. 2013 ;Volume 2013:5:11-22. Available from: http://www.dovepress.com/apolipoprotein-e-genotype-and-human-immunodeficiency-virus-associated--peer-reviewed-article-NBHIV

Grant I, Franklin D, Deutsch R, Woods SPaul, Vaida F, Ellis RJ, Letendre S, Marcotte TD, Atkinson JH, Collier AC, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.

Carlson D, Gelman B. Auditory function in patients with HIV/AIDS. In: American Speech Language Hearing Association Leader. Vol. 8. American Speech Language Hearing Association Leader. ; 2003. p. 15.

B

Gelman B, Schuenke KW. Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. Journal of NeuroVirology [Internet]. 2004 ;10(2):98-108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15204928

Gelman B, Schuenke KW. Brain Aging in AIDS: Increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not altered A beta-plaque accumulation. In: Journal of Neurovirology. Vol. 9. S3th ed. Journal of Neurovirology. ; 2003. p. 26.

Gelman B, Chen T, Lisinicchia JG, Carmical JR, Starkey JM, Luxon BA, Morgello S, Masliah E, Commins D, Brandt D, et al. Brain gene array reveals CNS adaptation and two different kinds of HIV-associated neurocognitive disorder. In: American Association of Neuropathologists 85 Annual Meeting. American Association of Neuropathologists 85 Annual Meeting. San Antonio, Texas; 2009. p. abstract #95.

C

Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 ;25(14):1747-51.

Soontornniyomkij V, Moore D, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, et al. Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS [Internet]. 2012 ;26(18):2327-2335. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23018443

Perez-Valero I, Ellis RJ, Heaton RK, Deutsch R, Franklin D, Clifford DB, Collier AC, Gelman B, Marra C, McCutchan JA, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.

Bharti AR, Letendre SL, Wolfson T, Clifford D, Collier AC, Gelman B, McArthur J, Marra C, McCutchan A, Morgello S, et al. Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. J Clin Virol. 2011 ;52(4):328-32.

Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis RJ, Cherner M, Gelman B, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of Neurovirology [Internet]. 2009 ;15:360-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20175693

Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.

D

Mukerjee R, Chang JR, Del-Valle L, Bagashev A, Gayed MM, Lyde RB, Hawkins BJ, Brailoiu E, Cohen E, Power C, et al. Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem [Internet]. 2011 ;286:34976-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=21816823

E

Saloner R, Heaton RK, Campbell LM, Chen A, Franklin D, Ellis RJ, Collier AC, Marra C, Clifford DB, Gelman B, et al. Effects of comorbidity burden and age on brain integrity in HIV. AIDS. 2019 ;33(7):1175-1185.

Lin K, Taylor MJ, Heaton R, Franklin D, Jernigan T, Fennema-Notestine C, McCutchan A, J Atkinson H, Ellis RJ, McArthur J, et al. Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals. J Clin Exp Neuropsychol. 2011 ;33(3):326-34.

Shah M, Smit TK, Morgello S, Tourtellotte W, Gelman B, Brew BJ, Saksena NK. Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage. AIDS Research and Human Retroviruses [Internet]. 2006 ;22:177-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16478400

Pages